Electronic Theses and Dissertations

Date of Award


Document Type


Degree Name

Ph.D. in Pharmaceutical Sciences

First Advisor

David A. Colby

Second Advisor

Sudeshna Roy

Third Advisor

Robert J. Doerksen


University of Mississippi

Relational Format



ABSTRACT The introduction of fluorine or fluorine containing moieties in pharmaceuticals may increase metabolic stability, binding affinity, bioavailability, lipophilicity, selectivity for targets, and fluorine-labelled groups can be used as imagining probes, i.e. in positron emission tomography (PET). Within the past decade, approximately 20% of all marketed pharmaceuticals contain fluorine and in 2018 alone 36% of the top 50 selling drugs on the market contained one or more fluorine atoms. Fluorinated reagents also plays an important role in the development of methods to introduce unique groups into an organic molecule, such as fluorination and methylenation. In this work, the scope of the trifluoroacetate release reaction was expanded to generate fluorinated lactam intermediates in oder to introduce an α-methylene into a lactam for the purposes of synthesizing L-γ-methyleneglutamine and amide derivatives. A fluorinated reagent was designed to allow the synthesis of compounds containing an α-fluoro-α,β-unsaturated carbonyl group and we attempt to produce organic molecules containing heavily fluorinated methylene carbons such as fluorotrifluoromethyl groups.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.